focus -WSS

focus

author：focus 2025-09-30 23:05:52 - browse：164

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb said that it would purchase Mirati Therapeutics, maker of the cancer drug Krazati, for $4.8 billion in cash in a deal that shows the continued interest of large pharmaceutical firms in relatively small “bolt-on” acquisitions.

Bristol said that it would pay $58.00 per share for Mirati, and would hold another $12.00 per share, or a total of $1 billion, to be paid if one of two different applications for an additional use for Krazati is approved within seven years after the merger closes.

Chris Boerner, Bristol’s chief operating officer and CEO-elect, said in a statement that Mirati had several cancer drugs in development that could deliver sales in the latter half of the decade and beyond, when investors worry that Bristol will need new products to sustain its growth.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Abortion clinic in Cancun will cater to Americans

knowledge

WSS

STAT Executive Editor Rick Berke on STAT's 8th birthday

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Medicare solvency divides Republicans at the presidential debate

Victims of gun violence feel impacts long after bullet wound

Does Medicare's free annual wellness visit do any good?

Senate panel clears PBM, hopsital reforms

hotspot

focus

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

Moonlake's readout produced a cash windfall. Risks remain

Biotech incubator Curie.Bio graduates its first startup

After affirmative action ruling, medical educators look to 'holistic review'

Ambulance rides for just $100? Advisers want major billing fixes

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Diversify hospital leadership teams to protect BIPOC patient health

Medical leaders decry Supreme Court decision on affirmative action

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

entertainment

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Prosecutors seek bail revocation for FTX founder Sam Bankman

Biotech incubator Curie.Bio graduates its first startup

10 million people disenrolled from Medicaid over past six months

Senate panel clears PBM, hopsital reforms

entertainment

knowledge

hotspot

entertainment